nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chlorhexidine and newborn omphalitis and mortality
|
Hodgins, Stephen |
|
2017 |
5 |
3 |
p. e270-e271 |
artikel |
2 |
Chlorhexidine and newborn omphalitis and mortality – Authors' reply
|
Osrin, David |
|
2017 |
5 |
3 |
p. e272-e273 |
artikel |
3 |
Community-based bundled interventions for reproductive and child health in informal settlements: evidence, efficiency, and equity
|
Padmadas, Sabu S |
|
2017 |
5 |
3 |
p. e240-e241 |
artikel |
4 |
Community resource centres to improve the health of women and children in informal settlements in Mumbai: a cluster-randomised, controlled trial
|
More, Neena Shah |
|
2017 |
5 |
3 |
p. e335-e349 |
artikel |
5 |
Correction to Lancet Glob Health 2017; 5: e290–99
|
|
|
2017 |
5 |
3 |
p. e276 |
artikel |
6 |
Correction to Lancet Glob Health 2013; 4: e642–53
|
|
|
2017 |
5 |
3 |
p. e275 |
artikel |
7 |
Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study
|
Cohen, Cheryl |
|
2017 |
5 |
3 |
p. e359-e369 |
artikel |
8 |
Establishing the Africa Centres for Disease Control and Prevention: responding to Africa's health threats
|
Nkengasong, John N |
|
2017 |
5 |
3 |
p. e246-e247 |
artikel |
9 |
Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis
|
Popova, Svetlana |
|
2017 |
5 |
3 |
p. e290-e299 |
artikel |
10 |
Evolving migrant crisis in Europe: implications for health systems
|
Carballo, Manuel |
|
2017 |
5 |
3 |
p. e252-e253 |
artikel |
11 |
First estimates of the global and regional incidence of neonatal herpes infection
|
Looker, Katharine J |
|
2017 |
5 |
3 |
p. e300-e309 |
artikel |
12 |
Harnessing the power of emotional drivers to promote behaviour change – Authors' Reply
|
Greenland, Katie |
|
2017 |
5 |
3 |
p. e265 |
artikel |
13 |
High global prevalence of alcohol use during pregnancy and fetal alcohol syndrome indicates need for urgent action
|
Tsang, Tracey W |
|
2017 |
5 |
3 |
p. e232-e233 |
artikel |
14 |
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
|
Li, Jing-Xin |
|
2017 |
5 |
3 |
p. e324-e334 |
artikel |
15 |
Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study
|
Marks, Florian |
|
2017 |
5 |
3 |
p. e310-e323 |
artikel |
16 |
In Morocco, the elimination of trachoma as a public health problem becomes a reality
|
Hammou, Jaouad |
|
2017 |
5 |
3 |
p. e250-e251 |
artikel |
17 |
Leaving no one behind: can the Family Planning Estimation Tool help?
|
Raj, Anita |
|
2017 |
5 |
3 |
p. e242-e243 |
artikel |
18 |
Levels and trends in contraceptive prevalence, unmet need, and demand for family planning for 29 states and union territories in India: a modelling study using the Family Planning Estimation Tool
|
New, Jin Rou |
|
2017 |
5 |
3 |
p. e350-e358 |
artikel |
19 |
Modelling approaches for tuberculosis: are they realistic?
|
Atre, Sachin |
|
2017 |
5 |
3 |
p. e268 |
artikel |
20 |
Modelling approaches for tuberculosis: are they realistic? – Authors' reply
|
Menzies, Nicolas A |
|
2017 |
5 |
3 |
p. e269 |
artikel |
21 |
Persistence of immune responses induced by Ebola virus vaccines
|
Snape, Matthew D |
|
2017 |
5 |
3 |
p. e238-e239 |
artikel |
22 |
Raising the red flag for malaria elimination and integrated fever surveillance in the Brazilian amazon
|
Siqueira, Andre M |
|
2017 |
5 |
3 |
p. e257-e258 |
artikel |
23 |
Reducing adolescent smoking in India
|
Barua, Mrinal Prakash |
|
2017 |
5 |
3 |
p. e266 |
artikel |
24 |
Reducing adolescent smoking in India – Authors' reply
|
Xi, Bo |
|
2017 |
5 |
3 |
p. e267 |
artikel |
25 |
Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: a systematic review
|
Allen, Luke |
|
2017 |
5 |
3 |
p. e277-e289 |
artikel |
26 |
Socioeconomic status and risk factors for non-communicable diseases in low-income and lower-middle-income countries
|
Stringhini, Silvia |
|
2017 |
5 |
3 |
p. e230-e231 |
artikel |
27 |
Surprise us, Mr Trump
|
The Lancet Global Health, |
|
2017 |
5 |
3 |
p. e229 |
artikel |
28 |
Sustainable clinical laboratory capacity for health in Africa
|
Davies, Justine |
|
2017 |
5 |
3 |
p. e248-e249 |
artikel |
29 |
The Ebola suspect's dilemma
|
Richardson, Eugene T |
|
2017 |
5 |
3 |
p. e254-e256 |
artikel |
30 |
Typhoid in Africa and vaccine deployment
|
Dougan, Gordon |
|
2017 |
5 |
3 |
p. e236-e237 |
artikel |
31 |
13-valent pneumococcal conjugate vaccine in Africa
|
Cohen, Robert |
|
2017 |
5 |
3 |
p. e244-e245 |
artikel |
32 |
Value of immunogenicity studies of influenza vaccine in resource-limited settings
|
de Silva, Thushan I |
|
2017 |
5 |
3 |
p. e274 |
artikel |
33 |
Why neonatal herpes matters
|
Kimberlin, David W |
|
2017 |
5 |
3 |
p. e234-e235 |
artikel |
34 |
Will you support a patient-centred R&D agreement?—Response from David Nabarro
|
Nabarro, David |
|
2017 |
5 |
3 |
p. e262 |
artikel |
35 |
Will you support a patient-centred R&D agreement?—Response from Flavia Bustreo
|
Bustreo, Flavia |
|
2017 |
5 |
3 |
p. e260 |
artikel |
36 |
Will you support a patient-centred R&D agreement?—Response from Miklós Szócska
|
Szócska, Miklós |
|
2017 |
5 |
3 |
p. e264 |
artikel |
37 |
Will you support a patient-centred R&D agreement?—Response from Philippe Douste-Blazy
|
Douste-Blazy, Philippe |
|
2017 |
5 |
3 |
p. e261 |
artikel |
38 |
Will you support a patient-centred R&D agreement?—Response from Sania Nishtar
|
Nishtar, Sania |
|
2017 |
5 |
3 |
p. e263 |
artikel |
39 |
Will you support a patient-centred R&D agreement?—Response from Tedros Adhanom Ghebreyesus
|
Ghebreyesus, Tedros Adhanom |
|
2017 |
5 |
3 |
p. e259 |
artikel |